🇺🇸 FDA
Pipeline program

CX-188

CTMX-M-188-001

Phase 1 small_molecule terminated

Quick answer

CX-188 for Solid Tumor, Adult is a Phase 1 program (small_molecule) at CytomX Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
CytomX Therapeutics
Indication
Solid Tumor, Adult
Phase
Phase 1
Modality
small_molecule
Status
terminated

Clinical trials